Ribavirin resistance in hepatitis C virus replicon-containing cell lines conferred by changes in the cell line or mutations in the replicon RNA.
about
Extinction of hepatitis C virus by ribavirin in hepatoma cells involves lethal mutagenesisResistance of Hepatitis C Virus to Inhibitors: Complexity and Clinical ImplicationsViral quasispecies evolutionDetection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system.Viral Determinants of Resistance to Treatment in Patients with Hepatitis CCharacterization of Hepatitis C Virus Subgenomic Replicon Resistance to Cyclosporine In VitroStudying Hepatitis C Virus: Making the Best of a Bad VirusIdentification of Residues Required for RNA Replication in Domains II and III of the Hepatitis C Virus NS5A ProteinEffects of Mutagenic and Chain-Terminating Nucleotide Analogs on Enzymes Isolated from Hepatitis C Virus Strains of Various GenotypesNaturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patientsReduced Ribavirin Antiviral Efficacy via Nucleoside Transporter-Mediated Drug ResistanceCounteracting Quasispecies Adaptability: Extinction of a Ribavirin-Resistant Virus Mutant by an Alternative Mutagenic TreatmentPotential benefits of sequential inhibitor-mutagen treatments of RNA virus infectionsCell type mediated resistance of vesicular stomatitis virus and Sendai virus to ribavirinDrugs in development for influenza.T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitroEthanol and reactive species increase basal sequence heterogeneity of hepatitis C virus and produce variants with reduced susceptibility to antivirals.Evaluation of anti-HIV-1 mutagenic nucleoside analogues.Host-based ribavirin resistance influences hepatitis C virus replication and treatment response.Coronaviruses: an RNA proofreading machine regulates replication fidelity and diversity.Treatment of interferon-alpha for chronic hepatitis C.Deep sequencing reveals mutagenic effects of ribavirin during monotherapy of hepatitis C virus genotype 1-infected patients.Mechanisms of viral emergence.Mechanism of action of ribavirin in the treatment of chronic hepatitis C.Arenaviruses and lethal mutagenesis. Prospects for new ribavirin-based interventions.Persistent hepatitis C virus infection impairs ribavirin antiviral activity through clathrin-mediated trafficking of equilibrative nucleoside transporter 1.Selection of hepatitis C virus resistant to ribavirin.Diagnosis and Management of Hepatitis C Virus Infection.Hepatitis C virus genetic variability and evolution.Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms.Cyclophilin inhibitors as a novel HCV therapy.Response of hepatitis C virus to long-term passage in the presence of alpha interferon: multiple mutations and a common phenotype.Mutations in HCV non-structural genes do not contribute to resistance to nitazoxanide in replicon-containing cells.Ribavirin can be mutagenic for arenaviruses.Determinants of RNA-dependent RNA polymerase (in)fidelity revealed by kinetic analysis of the polymerase encoded by a foot-and-mouth disease virus mutant with reduced sensitivity to ribavirin.Coevolution of the hepatitis C virus polyprotein sites in patients on combined pegylated interferon and ribavirin therapy.Comprehensive analysis for viral elements and interleukin-28B polymorphisms in response to pegylated interferon plus ribavirin therapy in hepatitis C virus 1B infection.Quasispecies and Drug Resistance
P2860
Q21132564-6FA10B3A-F1B7-4DAC-82AA-99D424A803F7Q26777408-F6571D17-E35A-49E5-986A-4117C0311913Q27013917-3EEBA091-3105-4AE9-AD2B-0D44C3A88365Q27472717-53C721B5-AC03-4302-AA42-20A6BFE7102FQ27478062-593F8A46-CB9D-4435-AD00-B759F08F7670Q27480361-3125A207-9CF3-49F0-A1C3-A8CB23A19C04Q27481034-E575BD08-A6F3-4805-8BAC-643DA8AE44F0Q27485314-3394981E-DB51-4EC8-B79A-D5F99DF6F62DQ27486248-CCEE9340-3D1C-4897-A418-1B70C3672E61Q27487949-17E66282-316E-4C09-9D15-35786D67BE81Q27488307-FF73BB05-2A12-4B8B-A38A-36D685D24EE9Q27488361-981856CB-F4DF-43C4-94F3-DCFDE03D9A6CQ28471847-4EE18662-81BA-461A-B083-7B5B8DE63BF0Q28474617-22B12981-77BE-43D4-8801-0B89CC6EDA09Q30391218-15ECFD57-B190-464D-831A-6958EC055929Q30426020-984C5363-3D28-4D45-AEC6-73CDBC967FA3Q34075689-94AC4F3D-FB12-43AF-9F44-AF602B4E3EDFQ34801497-7BB6A36A-DD61-4EBA-BFE4-E4EB53C0D2FFQ35077712-37829BF7-5718-41B2-9B95-209BF789E36FQ35079166-E739B0EE-612B-489B-B84F-13179F4B047AQ36491803-65EF5CC1-1CF7-4253-AB68-56EF86F1BF46Q36827155-71B2E4AA-E2CF-40B2-B259-65C1F7BF43A5Q37694793-81C7E0B7-FA5D-414C-BC3A-DB0F1613ED20Q37940977-B0C5F355-0CED-439C-A93C-C86AFAE1814DQ38064285-1C9A7321-3DB5-4718-AEBC-DE35D9E88FDBQ38262107-4B48C69C-F48B-4FA8-9281-B9BBFD705B2EQ38269623-FEF968E8-6519-4FB7-BBB6-A25A67BCD6BEQ38327430-CA2E165E-F4BB-4BCB-91ED-3777109092D0Q38456906-1BE955E5-C85F-49DF-84F5-9D6CBDD2AA45Q38543385-7F630C8C-078D-400B-A183-D28529B4103BQ38615621-260DFF02-06D3-4A1F-A01A-17B55C59DD8BQ39157496-7507B8CB-FEA6-410B-8E5E-33AD8B1608FEQ39518505-7C12D202-A166-4E9B-99C2-25CFC5A17FFFQ39544616-2A37A8DE-A0F4-4B0C-913F-9D97B575FC26Q41360264-CDEFE416-1AE4-47CB-A5E0-A80DAE62EA5AQ41841986-5F5BDC8B-F69C-407F-83C9-B5D5F89CFB28Q42980276-E5166F65-05D8-442A-AD32-5191E109B1B8Q56957250-8D19FD07-32E2-4426-B819-101DCC54715E
P2860
Ribavirin resistance in hepatitis C virus replicon-containing cell lines conferred by changes in the cell line or mutations in the replicon RNA.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Ribavirin resistance in hepati ...... mutations in the replicon RNA.
@ast
Ribavirin resistance in hepati ...... mutations in the replicon RNA.
@en
type
label
Ribavirin resistance in hepati ...... mutations in the replicon RNA.
@ast
Ribavirin resistance in hepati ...... mutations in the replicon RNA.
@en
prefLabel
Ribavirin resistance in hepati ...... mutations in the replicon RNA.
@ast
Ribavirin resistance in hepati ...... mutations in the replicon RNA.
@en
P2860
P1433
P1476
Ribavirin resistance in hepati ...... mutations in the replicon RNA.
@en
P2093
Julie K Pfeiffer
Karla Kirkegaard
P2860
P304
P356
10.1128/JVI.79.4.2346-2355.2005
P577
2005-02-01T00:00:00Z